Home
Biotheranostics

Biotheranostics Market Share Analysis for May 2026

Industry: N/A

Domainbiotheranostics.com

Year Founded2004

Employees51 - 200

Annual Revenue$25M - $50M

Biotheranostics

Biotheranostics (including company regionals)

biotheranostics.com

See more website traffic and engagement information

Biotheranostics Revenue up to May 2026 is 25M - 50M

revenue generated by Biotheranostics top domains

Biotheranostics top domains revenue over 3 years

Revenue for Biotheranostics top domains

biotheranostics.com25M - 50M

See more with Sales Intelligence

Total visits to Biotheranostics's top domains

Understand Biotheranostics market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Biotheranostics's top domains

Analyze Biotheranostics engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Biotheranostics's top domains

See how Biotheranostics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Biotheranostics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Biotheranostics

These are the website technologies, by industry, used by Biotheranostics top domains

Marketing (2)

Adobe Marketing Cloud

Advertising (1)

PubMatic

Business Solutions (1)

DocuSign

Content Management System (1)

Web Dot Com

More Technologies

6

See all

News & Signals from Biotheranostics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsZondler leaves Biotheranostics, Inc. as CIO.Zondler joins Veracyte from Biotheranostics, part of Hologic, where he served as CIO.

NewsBiotheranostics, Inc. launched CancerTYPE ID test on Jan 1st '10.Biotheranostics also developed and markets the CancerTYPE ID test, which provides a molecular diagnosis for patients with uncertain or unknown cancers.

NewsBiotheranostics, Inc. launches Not Another Minute campaign.Biotheranostics, Inc., announces the launch of its Not Another Minute campaign, revealing how Breast Cancer Index (BCI) is changing the game for early-stage, hormone receptor-positive (HR+) breast cancer patients.